Currently out of the existing stock ratings of Brian Skorney, 289 are a BUY (74.87%), 82 are a HOLD (21.24%), 15 are a SELL (3.89%).

Brian Skorney

Work Performance Price Targets & Ratings Chart

Analyst Brian Skorney, currently employed at BAIRD, carries an average stock price target met ratio of 63.62% that have a potential upside of 46.26% achieved within 361 days.

Brian Skorney’s has documented 762 price targets and ratings displayed on 47 stocks. The coverage is on Healthcare, Industrials, Basic Materials sectors.

Most recent stock forecast was given on AMGN, Amgen at 04-Aug-2026.

Wall Street Analyst Brian Skorney

Analyst best performing recommendations are on APLT (APPLIED THERAPEUTICS).
The best stock recommendation documented was for APLT (APPLIED THERAPEUTICS) at 1/8/2020. The price target of $43 was fulfilled within 1 day with a profit of $7.82 (22.23%) receiving and performance score of 222.29.

Average potential price target upside

of $127.73 (55.35%) on TTPH (TETRAPHASE PHARMACEUTICALS).
of $118.08 (58.13%) on ALB (ALBEMARLE CORP).
of $104.56 (58.49%) on ASMB (ASSEMBLY BIOSCIENCES).

ACHN Achillion Pharmaceuticals AIMT Aimmune Therapeutics ALBO Albireo Pharma AMGN Amgen AXON Axon Enterprise BIIB Biogen CELG Celgene CRIS Curis ENTA Enanta Pharmaceuticals GILD Gilead Sciences ICPT Intercept Pharmaceuticals MYOV Myovant Sciences Ltd NBIX Neurocrine Biosciences PRNB Principia Biopharma REGN Regeneron Pharmaceuticals RETA Reata Pharmaceuticals SRPT Sarepta Therapeutics TBPH Theravance Biopharma VRTX Vertex Pharmaceuticals VTGN VistaGen Therapeutics IMVT Immunovant PTI Proteostasis Therapeutics TTPH Tetraphase Pharmaceuticals VYGR Voyager Therapeutics RPHM Reneo Pharmaceuticals MRNS Marinus Pharmaceuticals APLT Applied Therapeutics CRNX Crinetics Pharmaceuticals INVA Innoviva MIRM Mirum Pharmaceuticals EIGR Eiger Biopharmaceuticals RGNX Regenxbio BHVN Biohaven Pharmaceutical Holding Co Ltd SLNO Soleno Therapeutics ANRO Alto Neuroscience ASMB Assembly Biosciences BGNE BeiGene Ltd BMRN Biomarin Pharmaceutical INSM Insmed ITMN InterMune NERV Minerva Neurosciences DYN Dyne Therapeutics ALB Albemarle Corp AXGT Sio Gene Therapies NRIX Nurix Therapeutics THRX Theseus Pharmaceuticals XENE Xenon Pharmaceuticals

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Liisa Bayko (EVERCORE)